sidroga prostata tee
sidroga gesellschaft für gesundheitsprodukte mbh (8127817) - brennnesselwurzel - arzneitee - brennnesselwurzel (945) 2,068 gramm
neydil nr. 24 d7
vitorgan arzneimittel gmbh (3091581) - prostata bovis (pot.-angaben) - flüssige verdünnung zur injektion - teil 1 - flüssige verdünnung zur injektion; prostata bovis (pot.-angaben) (09262) 20 milligramm
setistol prostata-kapseln
johannes bürger ysatfabrik gesellschaft mit beschränkter haftung (3015404) - phytosterol - hartkapsel - phytosterol (30143) 10 milligramm
adenoma prostata-injeel
biologische heilmittel heel gmbh - adenoma-prostata-nosode (pot.-angaben), adenoma-prostata-nosode (pot.-angaben), adenoma-prostata-nosode (pot.-angaben) - flüssige verdünnung zur injektion - adenoma-prostata-nosode (pot.-angaben) 0.367ml; adenoma-prostata-nosode (pot.-angaben) 0.367ml; adenoma-prostata-nosode (pot.-angaben) 0.367ml
adenoma prostata-injeel forte
biologische heilmittel heel gmbh - adenoma-prostata-nosode (pot.-angaben), adenoma-prostata-nosode (pot.-angaben), adenoma-prostata-nosode (pot.-angaben), adenoma-prostata-nosode (pot.-angaben) - flüssige verdünnung zur injektion - adenoma-prostata-nosode (pot.-angaben) 0.275ml; adenoma-prostata-nosode (pot.-angaben) 0.275ml; adenoma-prostata-nosode (pot.-angaben) 0.275ml; adenoma-prostata-nosode (pot.-angaben) 0.275ml
alpinamed prostata homöopathische tropfen
alpinamed ag - serenoa repens tm - homöopathische tropfen - serenoa repens tm endwerte. ethanolum 65 % v/v. - bei beginnenden prostatabeschwerden - homöopathische arzneimittel
prostadyn prostata-kapseln weichkapseln
dr. dünner ag - sabal extractum ethanolicum spissum - weichkapseln - sabal-extrakt ethanolicum dicke 160 mg, der: 10-14:1, auszugsmittel ethanolum 90 % m/m, excipiens für die kapsel. - zur linderung von prostatabeschwerden - phytoarzneimittel
vita prostata uno filmtabletten
doetsch grether ag - urticae radicis extractum methanolicum siccum (urtica dioica l., urtica urens l., radix) - filmtabletten - urticae radicis extractum methanolicum siccum (urtica dioica l., urtica urens l., radix) 600 mg, der: 7-14:1, auszugsmittel methanolum 20% (v/v), cellulosi pulvis, carboxymethylamylum natricum a corresp. natrium 4.3 mg, lactosum monohydricum 84.72 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 400, talcum, e 171, e 172, pro compresso obducto. - zur linderung von beschwerden infolge gutartiger vergrösserung der prostata - phytoarzneimittel
xtandi
astellas pharma europe b.v. - enzalutamid - prostata-neoplasmen - endokrine therapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
abiraterone mylan
mylan ireland limited - abirateronacetat - prostata-neoplasmen - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.